The global excipients market size is expected to reach USD 13.05 billion by 2030, registering a CAGR of 4.03% over the forecast period, according to a new report by Grand View Research, Inc. Globally increasing reach of generic medicines has been a major factor driving market growth. In addition, rising demand for newer excipients owing to the advantages of drug delivery and stability has led to the growth of the market.
Excipients are essential components for the improvement of overall pharmaceutical activity and performance, both of which directly impact the characteristics of pharmaceutical formulations. An excipient in the right proportion can improve the shelf life and bioavailability of a formulation. These can also be used in drug delivery mechanisms such as sustained release and rapid release drugs.
Polymers were the largest product category in 2021 based on revenue and volume and are expected to maintain a comparatively moderate growth rate over the forecast period. Microcrystalline cellulose was the leading polymer in this category, accounting for a share of over 26.0% in 2021.
Sugars are expected to observe the fastest growth over the coming years, exhibiting an estimated CAGR of 6.9% from 2022 to 2030. Sugars can play an instrumental role in increasing solubility, taste masking, dissolution, and drug delivery, which can drive its market.
The Market is significantly driven by the increasing demand for pharmaceutical products due to the COVID-10 virus outbreak. The development of the COVID-19 vaccine was one of the major drivers for this market growth. Many key organizations capitalized on the opportunities that arose during the pandemic and witnessed significant growth.
Request a free sample copy or view report summary: Excipients Market Report
Polymer excipients accounted for the largest revenue share in 2022 and is anticipated to dominate the market in the upcoming years owing to high demand
The global demand for sugar excipients was valued at over USD 1.02 billion in 2022 and is estimated to witness significant growth over the forecast period
Oral formulation segment held the largest market share in 2022. The high volume usage of oral formulation increases the demand for excipients such as stabilizers, emulsifiers, polymers, and solubilizing agents
Binders held the largest market share by function, attributable to their use in formulations for strengthening the bonding between particles and imparting flexibility in tablets and granules
The market in Asia Pacific is projected to witness fastest growth of 4.3% over the course of the forecast period. Several development projects undertaken across major economies, especially in emerging excipients markets are responsible for high growth.
Grand View Research has segmented the global excipients market on the basis of product, formulation, function, and region:
Excipients Product Outlook (Volume in Tons; Revenue in USD Million, 2018 - 2030)
Polymers
MCC
HPMC
Ethyl Cellulose
Methyl Cellulose
CMC
Croscarmellose Sodium
Povidone
Pregelatinized Starch
Sodium Starch Glycolate
Polyethylene Glycol
Acrylic Polymers
Alcohols
Glycerin
Propylene Glycol
Sorbitol
Mannitol
Others
Sugar
Lactose
Sucrose
Others
Minerals
Calcium Phosphate
Calcium Carbonate
Clay
Silicon Dioxide
Titanium Dioxide
Others
Gelatin
Excipients Formulation Outlook (Revenue in USD Million, 2018 - 2030)
Oral
Topical
Parenteral
Others
Excipients Function Outlook (Revenue in USD Million, 2018 - 2030)
Fillers and Diluents
Suspending & Viscosity Agents
Coating Agents
Binders
Flavoring Agents & Sweeteners
Disintegrants
Colorants
Lubricants and Glidants
Preservatives
Emulsifying Agents
Others
Excipients Regional Outlook (Volume, Tons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Denmark
Norway
Sweden
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Excipients Market
Eastman Chemical Corporation
P&G Chemicals
Avantor Performance Materials, LLC
Huntsman Corporation
BASF SE
Ashland Inc.
FMC Corporation
Roquette
Colorcon Inc.
Lubrizol Corporation
Valeant
JRS Pharma
Shin-Etsu Chemical Co., Ltd.
DFE Pharma
Finar Limited
"The quality of research they have done for us has been excellent..."